作者: Adrien Daigeler , Ludger Klein-Hitpass , Ansgar Michael Chromik , Oliver Müller , Jörg Hauser
关键词:
摘要: Background Doxorubicin is considered one of the most potent established chemotherapeutics in treatment liposarcoma; however, response rates usually below 30%, are still disappointing. This study was performed to identify gene expression changes liposarcoma after doxorubicin treatment.